Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma
H Betsunoh, S Mukai, Y Akiyama, T Fukushima… - Cancer …, 2007 - Wiley Online Library
Cell surface proteolysis is important for the generation of bioactive proteins mediating tumor
progression. Recent studies suggest that the membrane‐anchored cell surface proteinases …
progression. Recent studies suggest that the membrane‐anchored cell surface proteinases …
[引用][C] Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma
H BETSUNOH - Cancer Sci, 2007 - cir.nii.ac.jp
[PDF][PDF] Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma
H Betsunoh, S Mukai, Y Akiyama, T Fukushima… - 2007 - researchgate.net
Materials and Methods Clinical samples. The experimental protocol was approved by the
Human Ethics Review Committees of Miyazaki University and Koga General Hospital …
Human Ethics Review Committees of Miyazaki University and Koga General Hospital …
Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma
H Betsunoh, S Mukai, Y Akiyama… - Cancer …, 2007 - pubmed.ncbi.nlm.nih.gov
Cell surface proteolysis is important for the generation of bioactive proteins mediating tumor
progression. Recent studies suggest that the membrane-anchored cell surface proteinases …
progression. Recent studies suggest that the membrane-anchored cell surface proteinases …
Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma.
H Betsunoh, S Mukai, Y Akiyama, T Fukushima… - Cancer …, 2007 - europepmc.org
Cell surface proteolysis is important for the generation of bioactive proteins mediating tumor
progression. Recent studies suggest that the membrane-anchored cell surface proteinases …
progression. Recent studies suggest that the membrane-anchored cell surface proteinases …
[PDF][PDF] Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma
H Betsunoh, S Mukai, Y Akiyama, T Fukushima… - 2007 - academia.edu
Materials and Methods Clinical samples. The experimental protocol was approved by the
Human Ethics Review Committees of Miyazaki University and Koga General Hospital …
Human Ethics Review Committees of Miyazaki University and Koga General Hospital …
[HTML][HTML] Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma
H Betsunoh, S Mukai, Y Akiyama, T Fukushima… - Cancer …, 2007 - ncbi.nlm.nih.gov
Cell surface proteolysis is important for the generation of bioactive proteins mediating tumor
progression. Recent studies suggest that the membrane‐anchored cell surface proteinases …
progression. Recent studies suggest that the membrane‐anchored cell surface proteinases …
[引用][C] Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma
H BETSUNOH, S MUKAI, Y AKIYAMA… - Cancer …, 2007 - pascal-francis.inist.fr
Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2
expression in renal cell carcinoma CNRS Inist Pascal-Francis CNRS Pascal and Francis …
expression in renal cell carcinoma CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[引用][C] Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma
H Betsunoh, S Mukai, Y Akiyama, T Fukushima… - Cancer Science, 2007 - cir.nii.ac.jp
Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2
expression in renal cell carcinoma | CiNii Research CiNii 国立情報学研究所 学術情報 …
expression in renal cell carcinoma | CiNii Research CiNii 国立情報学研究所 学術情報 …